康宁corning耗材 291-3345 瓶顶过滤器-500ml容量,MF75TM系列,聚苯乙烯外壳,75mmSFCA滤膜,孔径0.45um,适合瓶颈尺寸33mm LSP Nalgene 12 12 1CS
月度归档:2023年09月
康宁corning耗材 291-3320 瓶顶过滤器-500ml容量,MF75TM系列,聚苯乙烯外壳,75mmSFCA滤膜,孔径0.2um,适合瓶颈尺寸33mm LSP Nalgene 12
康宁corning耗材 291-3320 瓶顶过滤器-500ml容量,MF75TM系列,聚苯乙烯外壳,75mmSFCA滤膜,孔径0.2um,适合瓶颈尺寸33mm LSP Nalgene 12 12 1CS
Lenalidomide-Br
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Lenalidomide-Br 纯度: 99.86%
Lenalidomide-Br (Compound 41) 是一种用于 E3 泛素连接酶的 cereblon (CRBN) 配体 Lenalidomide 的类似物,用于 CRBN 蛋白的募集。Lenalidomide-Br 可通过 linker 连接到蛋白质配体上形成 PROTAC,如 PROTAC STAT3 降解剂 SD-36 (HY-129602)。
![Lenalidomide-Br Chemical Structure Lenalidomide-Br](http://www.fluoroprobe.com/wp-content/uploads/2022/05/hy-43722.gif)
Lenalidomide-Br Chemical Structure
CAS No. : 2093387-36-9
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
100 mg | ¥4500 | In-stock | |
250 mg | ¥7000 | In-stock | |
500 mg | ¥9500 | In-stock | |
1 g | 询价 | ||
5 g | 询价 |
* Please select Quantity before adding items.
Lenalidomide-Br 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- Anti-Cancer Compound Library
- Ubiquitination Compound Library
生物活性 |
Lenalidomide-Br (Compound 41) is an analog of cereblon (CRBN) ligand Lenalidomide for E3 ubiquitin ligase, and is used in the recruitment of CRBN protein. Lenalidomide-Br can be connected to the ligand for protein by a linker to form PROTACs, such as the PROTAC STAT3 degrader SD-36 (HY-129602)[1][2]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
||||||||||||||||
体外研究 (In Vitro) |
Lenalidomide-Br 可以通过接头与蛋白质的配体连接以形成 PROTAC。PROTAC 是泛素介导的促癌蛋白降解的诱导剂[1][2]。 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
323.14 |
||||||||||||||||
Formula |
C13H11BrN2O3 |
||||||||||||||||
CAS 号 |
2093387-36-9 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 33.33 mg/mL (103.14 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
康宁corning耗材 290-4545 瓶顶过滤器-150ml,容量MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.45um,适合瓶颈尺寸45mm LSP Nalgene 12
康宁corning耗材 290-4545 瓶顶过滤器-150ml,容量MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.45um,适合瓶颈尺寸45mm LSP Nalgene 12 12 1CS
康宁corning耗材 290-4520 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.2um,适合瓶颈尺寸45mm LSP Nalgene 12
康宁corning耗材 290-4520 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.2um,适合瓶颈尺寸45mm LSP Nalgene 12 12 1CS
康宁corning耗材 290-3345 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.45um,适合瓶颈尺寸33mm LSP Nalgene 12
康宁corning耗材 290-3345 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.45um,适合瓶颈尺寸33mm LSP Nalgene 12 12 1CS
康宁corning耗材 290-3320 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.2um,适合瓶颈尺寸33mm LSP Nalgene 12
康宁corning耗材 290-3320 瓶顶过滤器-150ml容量,MF75TM系列,聚苯乙烯外壳,SFCA滤膜,孔径0.2um,适合瓶颈尺寸33mm LSP Nalgene 12 12 1CS
康宁corning耗材 169-0045 过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mmPES滤膜 LSP Nalgene 12
康宁corning耗材 169-0045 过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mmPES滤膜 LSP Nalgene 12 12 1CS
康宁corning耗材 168-0045 过滤装置-250ml容量,MF75TM系列,聚苯乙烯外壳;PES滤膜 LSP Nalgene 12
康宁corning耗材 168-0045 过滤装置-250ml容量,MF75TM系列,聚苯乙烯外壳;PES滤膜 LSP Nalgene 12 12 1CS
(S,R,S)-AHPC-C3-NH2 hydrochloride(Synonyms: VH032-C3-NH2 hydrochloride)
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
(S,R,S)-AHPC-C3-NH2 hydrochloride (Synonyms: VH032-C3-NH2 hydrochloride)
(S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) hydrochloride 是一种合成的 E3 连接酶配体-linker 偶联物 (E3 ligase ligand-linker conjugate,包含基于 VH032 的 VHL 配体和 1 个 linker,可用于合成 PROTAC 分子。
![(S,R,S)-AHPC-C3-NH2 hydrochloride Chemical Structure (S,R,S)-AHPC-C3-NH2 hydrochloride(Synonyms: VH032-C3-NH2 hydrochloride)](http://www.fluoroprobe.com/wp-content/uploads/2022/05/hy-130711b.gif)
(S,R,S)-AHPC-C3-NH2 hydrochloride Chemical Structure
规格 | 价格 | 是否有货 | |
---|---|---|---|
5 mg | ¥2800 | 询问价格 & 货期 |
* Please select Quantity before adding items.
生物活性 |
(S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology[1]. |
|
---|---|---|
IC50 & Target |
|
|
体外研究 (In Vitro) |
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only. |
|
分子量 |
552.13 |
|
Formula |
C26H38ClN5O4S |
|
运输条件 |
Room temperature in continental US; may vary elsewhere. |
|
储存方式 |
4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
|
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
1H-吲哚-3-甲醛对照品_487-89-8
【编号】:VIP(XL)05666
【产品名称】:1H-吲哚-3-甲醛对照品
【规格】:5mg;98%
【用途】:
1H-吲哚-3-甲醛对照品
![1H-吲哚-3-甲醛对照品_487-89-8](http://www.fluoroprobe.com/wp-content/uploads/2022/11/20221113_6370a7acf3dc5.jpg)
AZD-5069
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
AZD-5069 纯度: 99.53%
AZD-5069 是有效的 CXCR2 chemokine 受体拮抗剂,用于癌症的研究。
![AZD-5069 Chemical Structure AZD-5069](http://www.fluoroprobe.com/wp-content/uploads/2022/05/hy-19855.gif)
AZD-5069 Chemical Structure
CAS No. : 878385-84-3
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
10 mM * 1 mL in DMSO | ¥940 | In-stock | |
1 mg | ¥600 | In-stock | |
5 mg | ¥900 | In-stock | |
10 mg | ¥1500 | In-stock | |
25 mg | ¥2900 | In-stock | |
50 mg | ¥4500 | In-stock | |
100 mg | ¥8500 | In-stock | |
200 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
AZD-5069 相关产品
•相关化合物库:
- Drug Repurposing Compound Library Plus
- Clinical Compound Library Plus
- Bioactive Compound Library Plus
- GPCR/G Protein Compound Library
- Immunology/Inflammation Compound Library
- Anti-Cancer Compound Library
- Clinical Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Drug Repurposing Compound Library
- Endocrinology Compound Library
生物活性 |
AZD-5069 is a potent CXCR2 chemokine receptor antagonist, used for caner treatment. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
体外研究 (In Vitro) |
AZD-5069 (Compound 2) acts as CXCR2 antagonist by inhibition of [125I]-IL-8 binding to human CXCR2 receptors and as inhibitor of GROα-induced Ca2+ flux in human neutrophils loaded with fluo-3 dye[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
476.52 |
||||||||||||||||
Formula |
C18H22F2N4O5S2 |
||||||||||||||||
CAS 号 |
878385-84-3 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 90 mg/mL (188.87 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
α-Galactosylceramide(Synonyms: α-GalCer; KRN7000)
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
α-Galactosylceramide (Synonyms: α-GalCer; KRN7000) 纯度: 95.51%
α-Galactosylceramide (α-GalCer) 是一种合成的糖脂,具有抗肿瘤和免疫刺激作用。α-Galactosylceramide 是一种非常有效的 NKT 细胞激动剂,可与 CD1d 有效结合。α-Galactosylceramide 与 CD1d 的复合物可与 NKT 细胞的 T 细胞抗原受体结合。
![α-Galactosylceramide Chemical Structure α-Galactosylceramide(Synonyms: α-GalCer; KRN7000)](http://www.fluoroprobe.com/wp-content/uploads/2022/05/hy-102022.gif)
α-Galactosylceramide Chemical Structure
CAS No. : 158021-47-7
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
1 mg | ¥2400 | In-stock | |
5 mg | ¥7800 | 询价 | |
10 mg | ¥13500 | 询价 | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor)[1][2][3][4]. |
IC50 & Target |
NKT cell[3] |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Culture supernatants of activated Vα24+NKT-cell cultures stimulated with α-Galactosylceramide pulsed monocyte-derived dendritic cells (Mo-DCs) exhibits antiproliferative activities against melanoma cells. This effect is predominantly due to release of IFN-γ, and to a lesser extent IL-12. Other cytokines, including IL-4 and IL-10, are released but these cytokines have less antiproliferative effects. Vα24+NKT-cells stimulated by α-Galactosylceramide-pulsed Mo-DCs have anti-tumour activities against human melanoma through antiproliferative effects exerted by soluble mediators[3]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||
体内研究 (In Vivo) |
α-Galactosylceramide treatment can protect against spontaneous, carcinogen-, or oncogene-induced primary tumor formation in mice. Consistent with a prime role for IFN-γ in NKT cell-mediated tumor responses, a C-glycoside analog of α-Galactosylceramide that preferentially stimulated IFN-γ production is even more effective than α-Galactosylceramide at preventing metastases of the B16 melanoma[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||
Clinical Trial |
|
|||||||||
分子量 |
858.34 |
|||||||||
Formula |
C15H29NO9 |
|||||||||
CAS 号 |
158021-47-7 |
|||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
|||||||||
储存方式 |
|
|||||||||
溶解性数据 |
In Vitro:
DMSO : 0.5 mg/mL (0.58 mM; ultrasonic and warming and heat to 60°C) |
|||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
康宁corning耗材 167-0045 过滤装置-1000ml容量,MF75TM系列,聚苯乙烯外壳;90mmPES滤膜 LSP Nalgene 12
康宁corning耗材 167-0045 过滤装置-1000ml容量,MF75TM系列,聚苯乙烯外壳;90mmPES滤膜 LSP Nalgene 12 12 1CS
康宁corning耗材 166-0045 过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;75mmPES滤膜 LSP Nalgene 12
康宁corning耗材 166-0045 过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;75mmPES滤膜 LSP Nalgene 12 12 1CS
康宁corning耗材 165-0045 过滤装置-150ml容量,MF75TM系列,聚苯乙烯外壳;PES滤膜 LSP Nalgene 12
康宁corning耗材 165-0045 过滤装置-150ml容量,MF75TM系列,聚苯乙烯外壳;PES滤膜 LSP Nalgene 12 12 1CS
康宁corning耗材 164-0020 培养基过滤装置-1000ml容量,MF75TM系列,聚苯乙烯外壳;90mm尼龙滤膜,孔径0.2um LSP Nalgene 12
康宁corning耗材 164-0020 培养基过滤装置-1000ml容量,MF75TM系列,聚苯乙烯外壳;90mm尼龙滤膜,孔径0.2um LSP Nalgene 12 12 1CS
康宁corning耗材 163-0020 培养基过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mm尼龙滤膜,孔径0.2um LSP Nalgene 12
康宁corning耗材 163-0020 培养基过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mm尼龙滤膜,孔径0.2um LSP Nalgene 12 12 1CS
康宁corning耗材 162-0045 血清过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mmSFCA滤膜,孔径0.45um LSP Nalgene 12
康宁corning耗材 162-0045 血清过滤装置-500ml容量,MF75TM系列,聚苯乙烯外壳;90mmSFCA滤膜,孔径0.45um LSP Nalgene 12 12 1CS
Balixafortide TFA(Synonyms: POL6326 TFA)
上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Balixafortide TFA (Synonyms: POL6326 TFA) 纯度: 98.19%
Balixafortide TFA (POL6326 TFA) 是一种有效的,选择性的,耐受性好的肽类 CXCR4 拮抗剂,其 IC50 小于 10 nM。Balixafortide TFA 对 CXCR4 的选择性比包括 CXCR7 在内的许多受体高出 1000 倍。Balixafortide TFA 以 IC50 < 10 nM 阻断 β-arrestin 募集和钙通量。Balixafortide TFA 还是一种有效的造血干细胞和祖细胞 (HSPC) 动员剂,并具有抗癌作用。
![Balixafortide TFA Chemical Structure Balixafortide TFA(Synonyms: POL6326 TFA)](http://www.fluoroprobe.com/wp-content/uploads/2022/05/hy-p1682a.gif)
Balixafortide TFA Chemical Structure
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥1700 | In-stock | |
25 mg | ¥6200 | In-stock | |
50 mg | ¥10500 | In-stock | |
100 mg | 询价 | ||
200 mg | 询价 |
* Please select Quantity before adding items.
Balixafortide TFA 相关产品
•相关化合物库:
- Drug Repurposing Compound Library Plus
- Clinical Compound Library Plus
- Bioactive Compound Library Plus
- Peptide Library
生物活性 |
Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide TFA shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide TFA is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
||||||||||||||||
体外研究 (In Vitro) |
Balixafortide potently inhibits pERK / pAKT signaling in the lymphoma lines Namalwa (IC50< 200 nM) and Jurkat (IC50 < 400 nM). Balixafortide efficiently blocks SDF-1 dependent chemotaxis of MDA MB 231 breast cancer cells (IC50 < 20 nM), Namalwa and Jurkat cells (IC50 < 10 nM)[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
Balixafortide is optimized for favorable mouse absorption, distribution, metabolism and excretion (ADME) properties with balanced plasma protein binding, greater plasma and microsomal stability[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
1978.16 |
||||||||||||||||
Formula |
C86H119F3N24O23S2 |
||||||||||||||||
Sequence |
Cyclo(Ala-Cys-Ser-Ala-Pro-{Dab}-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro-Tyr-His)(Disulfide bridge: Cys2-Cys9) |
||||||||||||||||
Sequence Shortening |
Cyclo(ACSAP-{Dab}-RYCYQKPPYH)(Disulfide bridge: Cys2-Cys9) |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||||||||||||
溶解性数据 |
In Vitro:
H2O : 100 mg/mL (50.55 mM; Need ultrasonic) DMSO : 100 mg/mL (50.55 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务